These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3003312)

  • 1. Neurone specific enolase immunostaining in the diagnosis of breast carcinomas with neuroendocrine differentiation. Its usefulness and limitations.
    Nesland JM; Holm R; Johannessen JV; Gould VE
    J Pathol; 1986 Jan; 148(1):35-43. PubMed ID: 3003312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of different markers for neuroendocrine differentiation in breast carcinomas.
    Nesland JM; Holm R; Johannessen JV
    Pathol Res Pract; 1986 Oct; 181(5):524-30. PubMed ID: 2431399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear DNA content in breast carcinomas with neuroendocrine differentiation.
    Nesland JM; Pettersen EO; Fosså SD; Høie J; Johannessen JV
    J Pathol; 1986 Nov; 150(3):181-5. PubMed ID: 3027292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-erbB-2 protein and neuroendocrine expression in breast carcinomas.
    Nesland JM; Ottestad L; Heikilla R; Holm R; Tveit K; Børresen AL
    Anticancer Res; 1991; 11(1):161-7. PubMed ID: 1673329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical evidence for neuroendocrine differentiation in human breast carcinomas.
    Monaghan P; Roberts JD
    J Pathol; 1985 Dec; 147(4):281-9. PubMed ID: 3003310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine activity in metastatic breast carcinomas.
    Nesland JM; Holm R; Ottestad L; Karlsen KO; Johannessen JV
    APMIS Suppl; 1988; 2():204-14. PubMed ID: 2846016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-erbB-2 protein and neuroendocrine expression in intraductal carcinomas of the breast.
    Lilleng R; Hagmar BM; Nesland JM
    Mod Pathol; 1992 Jan; 5(1):41-7. PubMed ID: 1347423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine differentiation in breast lesions.
    Nesland JM; Holm R; Johannessen JV; Gould VE
    Pathol Res Pract; 1988 Apr; 183(2):214-21. PubMed ID: 3290869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast carcinomas with neuroendocrine differentiation.
    Nesland JM; Memoli VA; Holm R; Gould VE; Johannessen JV
    Ultrastruct Pathol; 1985; 8(2-3):225-40. PubMed ID: 4060259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine differentiation in colorectal carcinomas.
    Syversen U; Halvorsen T; Mårvik R; Waldum HL
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electron microscopy and immunostaining of the normal breast and its benign lesions. A search for neuroendocrine cells.
    Nesland JM; Lunde S; Holm R; Johannessen JV
    Histol Histopathol; 1987 Jan; 2(1):73-7. PubMed ID: 2980706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine carcinomas of the breast.
    Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
    Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostaining of neuron-specific enolase is a valuable aid to the cytological diagnosis of neuroendocrine tumours of the lung.
    Springall DR; Lackie P; Levene MM; Marangos PJ; Polak JM
    J Pathol; 1984 Aug; 143(4):259-65. PubMed ID: 6090626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast carcinomas with protein S-100 immunoreactivity. An immunocytochemical and ultrastructural study.
    Lunde S; Nesland JM; Holm R; Johannessen JV
    Pathol Res Pract; 1987 Oct; 182(5):627-31. PubMed ID: 2825146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms.
    Blobel GA; Gould VE; Moll R; Lee I; Huszar M; Geiger B; Franke WW
    Lab Invest; 1985 Jan; 52(1):39-51. PubMed ID: 2981372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.
    Tan PH; Lui GG; Chiang G; Yap WM; Poh WT; Bay BH
    Histopathology; 2004 Oct; 45(4):343-51. PubMed ID: 15469472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuron-specific enolase expression and neuroendocrine differentiation in carcinomas of the breast.
    Wilander E; Påhlman S; Sällström J; Lindgren A
    Arch Pathol Lab Med; 1987 Sep; 111(9):830-2. PubMed ID: 3632300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomorphology and marker expression of malignant neuroendocrine cells in pleural effusions.
    Banner BF; Warren WH; Gould VE
    Acta Cytol; 1986; 30(2):99-104. PubMed ID: 3008474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine profile in gastric carcinomas. An immunohistochemical study.
    Berner A; Nesland JM
    Histol Histopathol; 1991 Jul; 6(3):317-23. PubMed ID: 1725759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumours of the lung.
    Sheppard MN; Corrin B; Bennett MH; Marangos PJ; Bloom SR; Polak JM
    Histopathology; 1984 Mar; 8(2):171-81. PubMed ID: 6202617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.